Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

10.49
+0.73007.48%
Post-market: 10.490.00000.00%16:15 EDT
Volume:156.98K
Turnover:1.62M
Market Cap:154.47M
PE:-1.06
High:10.64
Open:9.64
Low:9.50
Close:9.76
52wk High:55.89
52wk Low:5.20
Shares:14.73M
Float Shares:10.53M
Volume Ratio:1.30
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.8800
EPS(LYR):-12.4806
ROE:-97.69%
ROA:-27.95%
PB:1.50
PE(LYR):-0.84

Loading ...

Oppenheimer Reaffirms Their Buy Rating on Korro Bio (KRRO)

TIPRANKS
·
Oct 06

Korro Bio Price Target Maintained with a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 06

Korro Bio Says First Participants Dosed in KRRO-121 Trial

MT Newswires Live
·
Oct 06

Korro Bio Doses First Healthy-Volunteer Cohort in Phase 1/2 Anchor Trial of KRRO-121

Reuters
·
Oct 06

Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (Anchor) for Krro-121

THOMSON REUTERS
·
Oct 06

Korro Bio - Dosing in Ucd Patients Expected to Start in H1 2027; Interim Readout in H2 2027

THOMSON REUTERS
·
Oct 06

Favorable FDA Readthrough De-Risks Korro’s KRRO-111; Buy Rating Reaffirmed with Unchanged $21 Price Target

TIPRANKS
·
Oct 02

Korro Bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Sep 12

Korro Bio Grants 5,000 Inducement Stock Options at USD 12.93 Per Share

Reuters
·
Sep 12

Korro Bio SVP Finance Oliver Dolan Disposes of USD 99,330 Common Shares

Reuters
·
Sep 11

Korro Bio CEO to Speak at Citi Biopharma Back to School Summit Fireside Chat

Reuters
·
Aug 27

Korro Bio Director Jean Francois Formela Disposes of 28,468 Common Shares for $398,552

Reuters
·
Aug 22

Korro Bio Price Target Maintained with a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 20

Korro Bio Advances KRRO-121 Into First Human Trial

TIPRANKS
·
Aug 20

Korro Bio Submits Ethics Review Request in Australia for KRRO-121 First-in-Human Trial

Reuters
·
Aug 20

Korro Bio Grants New Hire Stock Option for 600 Shares at USD 13.35 Each

Reuters
·
Aug 15

Korro Bio Director Jean Francois Formela Reports $29,922 Disposal of Common Shares

Reuters
·
Aug 14

Lynx1 Capital Reports $78,648 Korro Bio Common Shares Purchase

Reuters
·
Aug 13

Korro Bio, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Korro Bio, Inc. Expected to Post a Loss of $1.43 a Share - Earnings Preview

Reuters
·
Aug 08